CRH (NYSE: CRH) grows Q2 profit, agrees $8.5B Arcosa deal
Rhea-AI Filing Summary
CRH plc reported Q2 2026 total revenues of $10.8 billion, up 6% year over year. Net income was $1.5 billion, 13% higher, while Adjusted EBITDA was $2.6 billion, up 7%. Net income and Adjusted EBITDA margins improved to 14.0% and 24.4% respectively.
Americas Materials Solutions grew revenues 10% and Adjusted EBITDA 12%, and International Solutions delivered 5% revenue and 8% Adjusted EBITDA growth. Americas Building Solutions revenues fell 2% and Adjusted EBITDA 8%, mainly from divestitures and subdued residential demand, partly offset by strong energy, data and utility infrastructure activity.
CRH completed 11 acquisitions for $1.1 billion, including the $0.7 billion Axius Water deal, and realized $1.7 billion of divestiture and asset-sale proceeds. It agreed to acquire Arcosa for an enterprise value of about $8.5 billion and arranged a $5.8 billion bridge facility to support financing. Net Debt was $15.4 billion, with $3.1 billion of cash and $4.5 billion of undrawn committed facilities. The company declared a quarterly dividend of $0.39 per share, 5% above last year, repurchased 2.5 million shares for $0.3 billion in Q2 (year-to-date buybacks $0.7 billion), and reaffirmed 2026 guidance for net income of $3.9–$4.1 billion, Adjusted EBITDA of $8.1–$8.5 billion and diluted EPS of $5.60–$6.05.
Positive
- Q2 2026 net income was $1.5 billion, up 13% year over year, with net income margin improving to 14.0% from 13.1%.
- Q2 2026 Adjusted EBITDA reached $2.6 billion, a 7% increase, and Adjusted EBITDA margin edged up to 24.4% from 24.1%.
- CRH agreed an all-cash acquisition of Arcosa with an enterprise value of approximately $8.5 billion, reinforcing its U.S. aggregates and infrastructure position.
- The board announced a quarterly dividend of $0.39 per share, a 5% year-over-year increase, alongside $0.7 billion of year-to-date share repurchases.
Negative
- Net cash provided by operating activities for the first half of 2026 was $513 million, down from $719 million in the prior-year period, while Net Debt increased to $15.4 billion.
Filing Explained
No new buyback tranche is currently disclosed after July 28; future repurchases depend on a later review.
This
An 8-K reports specified material events, while CRH states that the results and Exhibit 99.1 are furnished rather than filed for Exchange Act Section 18 purposes, unless later expressly incorporated.
CRH says it will reevaluate the buyback program later, subject to market conditions, balance-sheet strength, capital-allocation priorities and other factors.
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Q2 2026 Total revenues: $10.8 billion
Q2 2026 Net income: $1.5 billion
Q2 2026 Adjusted EBITDA: $2.6 billion
+5 more
8 metrics
Q2 2026 Total revenues
$10.8 billion
Three months ended June 30, 2026; 6% ahead of Q2 2025
Q2 2026 Net income
$1.5 billion
Three months ended June 30, 2026; 13% higher than Q2 2025
Q2 2026 Adjusted EBITDA
$2.6 billion
Three months ended June 30, 2026; 7% increase year over year
Q2 2026 Net income margin
14.0%
Net income margin for Q2 2026 vs 13.1% in Q2 2025
Net Debt at June 30, 2026
$15.4 billion
Net Debt including short and long-term debt, cash and derivatives
Arcosa acquisition enterprise value
$8.5 billion
All-cash Arcosa transaction announced June 22, 2026
Quarterly dividend per share
$0.39
Dividend declared July 30, 2026; 5% increase on prior year
2026 Adjusted EBITDA guidance range
$8.1–$8.5 billion
Company’s full-year 2026 Adjusted EBITDA outlook
Key Terms
Adjusted EBITDA, Net Debt, bridge facility agreement, redeemable noncontrolling interests, +2 more
6 terms
Adjusted EBITDA financial
"Adjusted EBITDA* of $2.6 billion (Q2 2025: $2.5 billion)"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Net Debt financial
"Net Debt* at June 30, 2026, was $15.4 billion"
Net debt is the total amount a company owes after subtracting the cash and assets it has that can be used to pay off that debt. It shows how much debt is truly a burden, helping investors understand if a company is financially healthy or heavily borrowed. Think of it like calculating how much money you owe after using your savings to pay part of it.
bridge facility agreement financial
"entered into a bridge facility agreement for $5.8 billion"
A bridge facility agreement is a short-term loan contract that provides immediate cash to a company while it arranges longer-term financing or completes a sale. It matters to investors because it affects a company’s near-term liquidity, debt load and the timing or terms of permanent funding; like a temporary bridge that keeps traffic moving while a permanent span is built, it fills funding gaps and can change a company’s financial picture.
redeemable noncontrolling interests financial
"Net (income) attributable to redeemable noncontrolling interests"
A redeemable noncontrolling interest is a minority ownership stake in a company that the holder can force the company to buy back at a set price or under certain conditions. For investors this matters because it creates a future cash obligation and can be treated more like a liability than permanent equity, affecting a company’s reported debt, net income and valuation — think of it as a part-owner who can cash out, forcing the business to pay them.
non-GAAP financial measures financial
"CRH uses a number of non-GAAP financial measures to monitor"
Non-GAAP financial measures are numbers companies use to show their financial performance that exclude certain expenses or income. They help investors see how the company might perform without one-time costs or other unusual items, giving a different perspective from official reports. However, since they can be adjusted, they don’t always tell the full story and should be looked at alongside standard financial figures.
Organic Revenue financial
"Organic Revenue and Organic Adjusted EBITDA"
Organic revenue is the sales a company generates from its regular business activities after stripping out extra effects like revenue added or lost from buying or selling other businesses and from currency swings. Think of it as measuring how much a store’s own customers increased spending, not growth from opening new stores or temporary price moves; investors use it to judge the true strength and sustainability of a company’s core demand.
Earnings Snapshot
Total revenues: $10.8 billion · Guidance included
three months ended June 30, 2026
Total revenues
$10.8 billion
+6% vs Q2 2025
Net income
$1.5 billion
+13% vs Q2 2025
Adjusted EBITDA
$2.6 billion
+7% vs Q2 2025
Diluted EPS
$2.21
+14% vs Q2 2025
Guidance
For 2026, CRH guides to net income of $3.9–$4.1 billion, Adjusted EBITDA of $8.1–$8.5 billion, diluted EPS of $5.60–$6.05 and capital expenditure of $2.7–$2.9 billion.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How did CRH (CRH) perform financially in Q2 2026?
CRH delivered higher profits in Q2 2026, with revenue of $10.8 billion and net income of $1.5 billion. Adjusted EBITDA was $2.6 billion, net income margin improved to 14.0%, and diluted EPS rose to $2.21 from $1.94 in Q2 2025.
What is CRH (CRH)’s 2026 full-year financial guidance?
For 2026, CRH guides to net income of $3.9–$4.1 billion, Adjusted EBITDA of $8.1–$8.5 billion and diluted EPS of $5.60–$6.05. Capital expenditure is guided to $2.7–$2.9 billion, slightly lower than the previous $2.8–$3.0 billion range.
What major acquisitions and divestitures did CRH (CRH) undertake in Q2 2026?
In Q2 2026 CRH completed 11 acquisitions for $1.1 billion, including the $0.7 billion Axius Water deal. It also agreed to acquire Arcosa for an enterprise value of about $8.5 billion and realized $1.7 billion of proceeds from divestitures and asset sales.
How is CRH (CRH)’s balance sheet and liquidity positioned after Q2 2026?
At June 30, 2026, CRH reported Net Debt of $15.4 billion and held $3.1 billion of cash and restricted cash. The company also had $4.5 billion of undrawn committed facilities to May 2030 and a $5.8 billion bridge facility linked to the Arcosa acquisition.
How did CRH (CRH)’s business segments perform in Q2 2026?
Americas Materials Solutions grew revenues 10% and Adjusted EBITDA 12%. International Solutions increased revenues 5% and Adjusted EBITDA 8%. Americas Building Solutions saw revenues fall 2% and Adjusted EBITDA decline 8%, mainly due to divestitures and softer residential demand.
What is the status of CRH (CRH)’s proposed Arcosa acquisition?
CRH agreed to acquire Arcosa in an all-cash deal valuing it at about $8.5 billion. The transaction is expected to close in Q1 2027, subject to Arcosa stockholder approval, regulatory approvals and other customary closing conditions.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 30, 2026
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | ||
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | |||||||||||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)
| Emerging Growth Company | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Item 2.02 Results of Operations and Financial Condition.
On July 30, 2026, CRH plc (the ‘Company’) issued a press release announcing the financial results of the Company for the fiscal quarter ended June 30, 2026. A copy of the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The Company will host an earnings conference call and webcast presentation to discuss its quarterly results on July 30, 2026, at 8:00 a.m. (EDT). Investors and members of the public can register for the conference call at www.crh.com/investors.
The information set forth under “Item 2.02 - Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto, is being “furnished” pursuant to Item 2.02 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the ‘Exchange Act’), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | |||||||
99.1 | Press release dated July 30, 2026, relating to financial results for the fiscal quarter ended June 30, 2026. | |||||||
104 | Cover Page Interactive Data File (formatted in Inline XBRL). | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 30, 2026
| CRH plc | ||||||||||||||||||||
| /s/ Aylwyn Bryan | ||||||||||||||||||||
| By: | Aylwyn Bryan | |||||||||||||||||||
| Chief Financial Officer | ||||||||||||||||||||
Exhibit 99.1
 | CRH Reports Second Quarter 2026 Results | |||||||||||||
•Strong quarter driven by good commercial management, favorable underlying demand and contributions from acquisitions •Increases in revenues, profits and margins reflecting continued execution of the CRH Winning Way •Active portfolio management; continuing to build a higher-growth connected portfolio •$1.4bn invested in 17 value-accretive acquisitions year-to-date; $8.5bn agreement to acquire Arcosa1 •Reinforcing CRH’s position as the leading aggregates & critical infrastructure player in North America •Outlook positive; expecting another year of growth underpinned by our superior strategy and connected portfolio •Reaffirming FY26 guidance for Net income ($3.9bn-$4.1bn), Adj. EBITDA* ($8.1bn-$8.5bn) and Diluted EPS ($5.60-$6.05) | |||||||||||
NEW YORK (Jul. 30, 2026) – CRH (NYSE: CRH), the leading provider of building materials, today reported second quarter 2026 financial results. Total revenues of $10.8 billion (Q2 2025: $10.2 billion) were 6% ahead of the prior year driven by positive pricing momentum, good underlying demand, and contributions from acquisitions. Net income of $1.5 billion (Q2 2025: $1.3 billion) was 13% higher than the prior year, driven by strong operating performance and gains on divestitures during the period. Adjusted EBITDA* of $2.6 billion (Q2 2025: $2.5 billion) increased by 7% over the prior year, reflecting disciplined commercial execution, strong performance improvement initiatives and contributions from acquisitions. CRH’s net income margin of 14.0% (Q2 2025: 13.1%) and Adjusted EBITDA margin* of 24.4% (Q2 2025: 24.1%) were both ahead of the prior year.1
Jim Mintern, Chief Executive Officer, stated “We delivered a strong Q2 performance driven by good commercial execution, favorable underlying demand and further contributions from acquisitions. Our unmatched scale, connected portfolio and leading performance supported higher profits and margin expansion against an inflationary cost backdrop. We remain focused on active portfolio management, completing three non-core divestitures, while reallocating capital into higher-growth, connected businesses. Backed by our robust balance sheet and financial capacity, we agreed the $8.5 billion acquisition of Arcosa, which will reinforce our position as the leading aggregates and critical infrastructure player in North America. Notwithstanding current geopolitical and macroeconomic uncertainties, we remain encouraged by the underlying demand across our key markets and are pleased to reaffirm our guidance for 2026 Net income, Adjusted EBITDA* and Diluted EPS, leaving us well positioned to deliver another year of growth and value creation.”
Summary Financials | Q2 2026 | YOY Change | ||||||
Total revenues | $10.8bn | +6% | ||||||
Net income | $1.5bn | +13% | ||||||
Net income margin | 14.0% | +90bps | ||||||
Adjusted EBITDA* | $2.6bn | +7% | ||||||
Adjusted EBITDA margin* | 24.4% | +30bps | ||||||
Diluted Earnings Per Share | $2.21 | +14% | ||||||
1Transaction remains subject to approval of Arcosa’s stockholders, regulatory approvals, and other customary closing conditions.
*Represents a non-GAAP financial measure. See 'Non-GAAP Reconciliation and Supplementary Information' on pages 11 to 12.
Exhibit 99.1
Three months ended June 30, 2026
Americas Materials Solutions' Total revenues were 10% ahead of the second quarter of 2025, driven by positive pricing momentum and contributions from acquisitions. Adjusted EBITDA increased by 12% year-over-year, reflecting disciplined cost management and contributions from acquisitions.
Americas Building Solutions' Total revenues decreased 2% compared to the second quarter of 2025 as the impact of divestitures and subdued residential demand offset strong performance in the energy and data infrastructure markets, supported by higher data center activity. Adjusted EBITDA declined 8% year-over-year, driven by divestitures, subdued residential demand and cost inflation, partly offset by strong demand in our utility infrastructure markets and performance improvement initiatives.
International Solutions' Total revenues were 5% ahead of the second quarter of 2025, as positive pricing momentum, increased activity levels in certain markets and contributions from acquisitions more than offset the impact of divestitures. Adjusted EBITDA was 8% ahead of the prior year quarter, reflecting disciplined commercial execution and operational excellence initiatives more than offsetting higher costs.
Please refer to Appendix 1 on pages 5 to 6 for detailed business segment information for the three months ended June 30, 2026.
Acquisitions and Divestitures
CRH continued its proven track record of allocating capital into high-growth, connected businesses that maximize value for shareholders. In the three months ended June 30, 2026, CRH completed 11 value-accretive acquisitions for a total consideration of $1.1 billion. Americas Materials Solutions completed five acquisitions, Americas Building Solutions completed two acquisitions and International Solutions completed four acquisitions. The largest acquisition, which completed on May 29, 2026, was the acquisition of Axius Water for a total consideration of $0.7 billion. Axius Water is a leading provider of specialized water quality solutions in North America.
On June 22, 2026, the Company announced a definitive agreement to acquire Arcosa, Inc. (‘Arcosa’), a leading U.S. provider of infrastructure-related materials, products and solutions, headquartered in Dallas, Texas, in an all-cash transaction for $150 per share reflecting a total enterprise value of approximately $8.5 billion. Arcosa is highly complementary to CRH, advancing the Company’s connected portfolio strategy. The transaction reinforces CRH’s position as the leader in U.S. aggregates, expands our capabilities in U.S. energy infrastructure, and increases exposure to some of the fastest-growing Metropolitan Statistical Areas in the U.S. The acquisition is expected to close in Q1 2027 subject to approval of Arcosa’s stockholders, regulatory approvals, and other customary closing conditions.
In the three months ended June 30, 2026, CRH also realized proceeds from divestitures and disposals of long-lived assets of $1.7 billion, net of disposal costs and deferred proceeds. These primarily comprised the divestiture of three non-core businesses: CRH's construction accessories operations for $0.7 billion, lawn and garden operations for $1.1 billion, and MoistureShield, a manufacturer of composite decking for $0.1 billion.
Other Financial Items
Depreciation, depletion and amortization charges of $548 million were $20 million higher than the prior year (Q2 2025: $528 million), primarily due to the impact of acquisitions.
Interest income of $22 million was lower than the comparable period (Q2 2025: $30 million), primarily due to lower interest rates and cash on deposit. Interest expense of $220 million was higher than the comparable period (Q2 2025: $200 million), primarily due to an increase in gross debt balances.
Income tax expense of $661 million (Q2 2025: $425 million) was higher than the prior year, mainly due to the impact of divestitures in the period.
Other nonoperating income, net, was $282 million, primarily related to gains on divestitures, compared with an expense of $9 million in Q2 2025.
Diluted Earnings Per Share (EPS) of $2.21 was ahead of the prior year (Q2 2025: $1.94), primarily due to strong operating performance and gains on divestitures.
Balance Sheet and Liquidity
Total short and long-term debt was $17.9 billion at June 30, 2026, compared with $17.7 billion at December 31, 2025.
Net Debt* at June 30, 2026, was $15.4 billion, compared to $14.2 billion at December 31, 2025. The increase in Net Debt* reflects acquisitions, purchases of property, plant and equipment, as well as cash returns to shareholders through share buybacks and dividends, partially offset by inflows from operating activities and proceeds from divestitures. CRH ended Q2 2026 with $3.1 billion of cash and cash equivalents and restricted cash on hand (June 30, 2025: $2.9 billion).
As of June 30, 2026, the Company had $4.5 billion of undrawn committed facilities available for use for general corporate purposes, which were available until May 2030. As of June 30, 2026, the Company had entered into a bridge facility agreement for $5.8 billion, the purpose of which was to finance, in part, the consideration payable in connection with the Arcosa Acquisition, the refinancing of certain of Arcosa’s existing debt and related fees and expenses. CRH remains committed to maintaining its robust balance sheet and expects to maintain a strong investment-grade credit rating.
CRH Q2 2026 Results 2
Exhibit 99.1
Dividends and Share Buybacks
In line with its policy of consistent long-term dividend growth, on July 30, 2026, CRH announced a quarterly dividend of $0.39 per share, representing a 5% increase on the prior year. The dividend will be paid on September 16, 2026, to shareholders registered at the close of business on August 14, 2026.
As part of its share buyback program, in the three months ended June 30, 2026, CRH repurchased approximately 2.5 million Ordinary Shares for a total consideration of $0.3 billion, compared to 3.7 million Ordinary Shares repurchased for a total consideration of $0.3 billion in the three months ended June 30, 2025. On July 28, 2026, the latest tranche of the share buyback program was completed, bringing the year-to-date repurchases to $0.7 billion. As announced on June 22, 2026, in connection with the agreement to acquire Arcosa, CRH has not initiated a new tranche of its share buyback program. CRH will reevaluate its share buyback program at a later date, subject to market conditions, balance sheet strength, capital allocation priorities and other factors.
2026 Full Year Outlook
We are pleased to reaffirm our 2026 Net income, Adjusted EBITDA* and Diluted EPS guidance. We expect favorable underlying demand across our key end-markets, underpinned by significant public investment in infrastructure and continued reindustrialization activity. Within the residential sector we anticipate resilient repair and remodel activity, while the new-build segment is expected to remain subdued. Assuming normal seasonal weather patterns and absent any further major dislocations in the geopolitical or macroeconomic environment, CRH's superior strategy, connected portfolio and leading positions of scale in attractive high-growth markets, together with our strong and flexible balance sheet, are expected to underpin another year of growth and value creation in 2026.
| 2026 Guidance (i) | ||||||||
| (in $ billions, except per share data) | Low | High | ||||||
| Net income (ii) | 3.9 | 4.1 | ||||||
| Adjusted EBITDA* | 8.1 | 8.5 | ||||||
| Diluted EPS (ii) | $5.60 | $6.05 | ||||||
| Capital expenditure (iii) | 2.7 | 2.9 | ||||||
| (i) The 2026 guidance does not assume any significant one-off or non-recurring items, including the impact of further potential changes to global trade policies, impairments or other unforeseen events. | ||||||||
| (ii) 2026 Net income and Diluted EPS are based on approximately $0.7 billion of interest expense, net, an effective tax rate of approximately 26% and a year-to-date average of approximately 674 million diluted Common Shares outstanding. | ||||||||
| (iii) 2026 capital expenditure guidance is being updated from the previous range of $2.8 billion to $3.0 billion to a new range of $2.7 billion to $2.9 billion to reflect project timing and lower maintenance spend. | ||||||||
Q2 2026 Conference Call
CRH will host a conference call and webcast presentation at 8:00 a.m. (EDT) on Thursday, July 30, 2026, to discuss its Q2 2026 results and outlook. Registration details are available on www.crh.com/investors. Upon registration, a link to join the call and dial-in details will be made available. The accompanying investor presentation will be available on the investor section of the CRH website in advance of the conference call, and a recording of the conference call will be made available afterwards.
About CRH
CRH is the leading provider of building materials critical to modernizing infrastructure. With our team of 83,000 people across 4,000 locations, our unmatched scale, connected portfolio, and deep local relationships make us the partner of choice for transportation, water, and reindustrialization projects, shaping communities for a better tomorrow. CRH (NYSE: CRH) is a member of the S&P 500 Index. For more information, visit www.crh.com.
CRH Q2 2026 Results 3
Exhibit 99.1
Appendices
CRH Q2 2026 Results 4
Exhibit 99.1
Appendix 1 - Results Of Operations
Three months ended June 30, 2026
Americas Materials Solutions
| Analysis of Change | |||||||||||||||||||||||
| in $ millions | Q2 2025 | Currency | Acquisitions | Divestitures | Organic | Q2 2026 | % change | ||||||||||||||||
| Total revenues | 4,509 | – | +312 | (34) | +170 | 4,957 | +10% | ||||||||||||||||
| Adjusted EBITDA | 1,241 | – | +69 | +2 | +72 | 1,384 | +12% | ||||||||||||||||
| Adjusted EBITDA margin | 27.5% | 27.9% | |||||||||||||||||||||
Americas Materials Solutions' Total revenues were 10% ahead of the second quarter of 2025, driven by positive pricing momentum and contributions from acquisitions.
In Essential Materials, Total revenues increased by 20%, reflecting positive pricing momentum in aggregates and contributions from acquisitions, mainly the 2025 acquisition of Eco Material Technologies. Aggregates volumes increased by 2%, while cement volumes declined by 2% impacted by adverse weather in certain markets and subdued residential demand. Aggregates prices increased by 5%, while cement prices were 1% behind the comparable period in 2025 reflecting adverse geographic mix-effects.
In Road Solutions, Total revenues were 6% ahead of the prior year, driven by good underlying demand, disciplined commercial execution and contributions from acquisitions. Asphalt volumes increased by 3%, while pricing increased by 6%. Readymixed concrete volumes were in line with the prior year, while pricing was up 2%. Paving and construction revenues increased by 5%, supported by project execution, backlog conversion, and contributions from acquisitions.
Adjusted EBITDA for Americas Materials Solutions was 12% ahead of the prior year, supported by positive pricing momentum, disciplined cost management and contributions from acquisitions. Adjusted EBITDA margin was 40bps ahead of the second quarter of 2025.
Americas Building Solutions
| Analysis of Change | |||||||||||||||||||||||
| in $ millions | Q2 2025 | Currency | Acquisitions | Divestitures | Organic | Q2 2026 | % change | ||||||||||||||||
| Total revenues | 2,159 | – | +5 | (192) | +145 | 2,117 | (2%) | ||||||||||||||||
| Adjusted EBITDA | 501 | – | +20 | (37) | (22) | 462 | (8%) | ||||||||||||||||
| Adjusted EBITDA margin | 23.2% | 21.8% | |||||||||||||||||||||
Americas Building Solutions' Total revenues were 2% behind the second quarter of 2025, as strong data center and utility infrastructure demand was offset by the impact of divestitures.
In Building & Infrastructure Solutions, Total revenues were 10% ahead of the second quarter of 2025, driven by strong performance in the energy and data infrastructure markets.
In Outdoor Living Solutions, Total revenues were 7% behind the prior year period, reflecting the impact of divestitures and subdued residential demand.
Americas Building Solutions' Adjusted EBITDA was 8% behind the second quarter of 2025, reflecting the impact of divestitures, cost inflation and subdued residential demand, partly offset by strong demand in our utility infrastructure markets and ongoing performance improvement initiatives. Adjusted EBITDA margin was 140bps behind the second quarter of 2025.
CRH Q2 2026 Results 5
Exhibit 99.1
International Solutions
| Analysis of Change | |||||||||||||||||||||||
| in $ millions | Q2 2025 | Currency | Acquisitions | Divestitures | Organic | Q2 2026 | % change | ||||||||||||||||
| Total revenues | 3,538 | +89 | +226 | (203) | +53 | 3,703 | +5% | ||||||||||||||||
| Adjusted EBITDA | 721 | +14 | +40 | (19) | +25 | 781 | +8% | ||||||||||||||||
| Adjusted EBITDA margin | 20.4% | 21.1% | |||||||||||||||||||||
International Solutions' Total revenues were 5% ahead of the second quarter of 2025 as positive pricing momentum, increased activity levels in certain markets, and contributions from acquisitions more than offset the impact of divestitures.
In Essential Materials, Total revenues were 15% ahead of the comparable period in 2025. Aggregates and cement volumes were 10% and 6% ahead of the prior year period, respectively, with increased activity in certain markets, further supported by acquisitions. Aggregates and cement pricing were 2% and 4% ahead of the prior year period, respectively.
In Road Solutions, Total revenues were 3% behind the comparable period in 2025, impacted by divestitures. Readymixed concrete volumes were 5% ahead of the prior year period, supported by acquisitions, while pricing was 3% ahead. Asphalt volumes were 7% behind the prior year period as a result of lower activity levels in certain markets, while pricing was 20% ahead, benefiting from geographic mix-effects.
Within Building & Infrastructure Solutions and Outdoor Living Solutions, Total revenues were 1% behind the comparable period in 2025, reflecting the impact of divestitures.
Adjusted EBITDA in International Solutions was 8% ahead of the second quarter of 2025, benefiting from positive pricing momentum, operational excellence initiatives and contributions from acquisitions which more than offset the impact of divestitures and cost inflation. Adjusted EBITDA margin increased by 70bps.
CRH Q2 2026 Results 6
Exhibit 99.1
Appendix 2 - Financial Statements
The following financial statements are an extract of the Company’s Condensed Consolidated Financial Statements prepared in accordance with U.S. GAAP for the three and six months ended June 30, 2026, and do not present all necessary information for a complete understanding of the Company's financial condition as of June 30, 2026 and its results of operations for the interim periods then ended. The full Condensed Consolidated Financial Statements prepared in accordance with U.S. GAAP for the three months ended June 30, 2026, including notes thereto, will be included as a part of the Company’s Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (SEC).
Condensed Consolidated Statements of Income (Unaudited)
(in $ millions, except share and per share data)
| Three months ended | Six months ended | |||||||||||||
| June 30 | June 30 | |||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||
| Product revenues | 8,491 | 7,919 | 14,725 | 13,531 | ||||||||||
| Service revenues | 2,286 | 2,287 | 3,422 | 3,431 | ||||||||||
| Total revenues | 10,777 | 10,206 | 18,147 | 16,962 | ||||||||||
| Cost of product revenues | (4,429) | (4,083) | (8,680) | (7,909) | ||||||||||
| Cost of service revenues | (2,054) | (2,097) | (3,128) | (3,190) | ||||||||||
| Total cost of revenues | (6,483) | (6,180) | (11,808) | (11,099) | ||||||||||
| Gross profit | 4,294 | 4,026 | 6,339 | 5,863 | ||||||||||
| Selling, general and administrative expenses | (2,267) | (2,120) | (4,324) | (3,953) | ||||||||||
| Gain on disposal of long-lived assets | 52 | 29 | 74 | 43 | ||||||||||
| Loss on impairments | – | – | (48) | – | ||||||||||
| Operating income | 2,079 | 1,935 | 2,041 | 1,953 | ||||||||||
| Interest income | 22 | 30 | 43 | 67 | ||||||||||
| Interest expense | (220) | (200) | (423) | (381) | ||||||||||
| Other nonoperating income (expense), net | 282 | (9) | 278 | (29) | ||||||||||
| Income from operations before income tax expense and income from equity method investments | 2,163 | 1,756 | 1,939 | 1,610 | ||||||||||
| Income tax expense | (661) | (425) | (606) | (367) | ||||||||||
| Income (loss) from equity method investments | 9 | 1 | (2) | (9) | ||||||||||
| Net income | 1,511 | 1,332 | 1,331 | 1,234 | ||||||||||
| Net (income) attributable to redeemable noncontrolling interests | (10) | (8) | (10) | (8) | ||||||||||
| Net (income) attributable to noncontrolling interests | (15) | (5) | (11) | (1) | ||||||||||
| Net income attributable to CRH | 1,486 | 1,319 | 1,310 | 1,225 | ||||||||||
| Earnings per share attributable to CRH | ||||||||||||||
| Basic | $2.22 | $1.95 | $1.94 | $1.79 | ||||||||||
| Diluted | $2.21 | $1.94 | $1.93 | $1.78 | ||||||||||
| Weighted average common shares outstanding | ||||||||||||||
| Basic | 667.2 | 674.8 | 667.9 | 675.8 | ||||||||||
| Diluted | 668.8 | 677.7 | 670.3 | 679.9 | ||||||||||
CRH Q2 2026 Results 7
Exhibit 99.1
Condensed Consolidated Balance Sheets (Unaudited)
(in $ millions, except share data)
| June 30 | December 31 | June 30 | |||||||||
| 2026 | 2025 | 2025 | |||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | 3,025 | 4,096 | 2,876 | ||||||||
| Restricted cash | 58 | 51 | – | ||||||||
Accounts receivable, net of allowance for credit losses of $136 million, $137 million, and $151 million as of June 30, 2026, December 31, 2025, and June 30, 2025, respectively | 6,777 | 5,178 | 6,490 | ||||||||
| Inventories | 5,103 | 5,251 | 5,051 | ||||||||
| Other current assets | 789 | 678 | 734 | ||||||||
| Total current assets | 15,752 | 15,254 | 15,151 | ||||||||
| Property, plant and equipment, net | 24,885 | 24,937 | 23,017 | ||||||||
| Equity method investments | 464 | 502 | 712 | ||||||||
| Goodwill | 13,150 | 13,099 | 11,673 | ||||||||
| Intangible assets, net | 2,037 | 2,048 | 1,239 | ||||||||
| Operating lease right-of-use assets, net | 1,285 | 1,471 | 1,295 | ||||||||
| Other noncurrent assets | 979 | 1,018 | 897 | ||||||||
| Total assets | 58,552 | 58,329 | 53,984 | ||||||||
| Liabilities, redeemable noncontrolling interests and shareholders’ equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | 3,535 | 3,263 | 3,303 | ||||||||
| Accrued expenses | 2,046 | 2,196 | 2,266 | ||||||||
| Current portion of long-term debt | 2,516 | 1,175 | 1,171 | ||||||||
| Operating lease liabilities | 258 | 286 | 247 | ||||||||
| Other current liabilities | 1,622 | 1,834 | 1,697 | ||||||||
| Total current liabilities | 9,977 | 8,754 | 8,684 | ||||||||
| Long-term debt | 15,410 | 16,478 | 14,642 | ||||||||
| Deferred income tax liabilities | 3,509 | 3,511 | 3,202 | ||||||||
| Noncurrent operating lease liabilities | 1,069 | 1,232 | 1,096 | ||||||||
| Other noncurrent liabilities | 3,052 | 2,876 | 2,730 | ||||||||
| Total liabilities | 33,017 | 32,851 | 30,354 | ||||||||
| Redeemable noncontrolling interests | 435 | 430 | 389 | ||||||||
| Shareholders’ equity | |||||||||||
| Preferred stock, €1.27 par value, nil, 150,000 and 150,000 shares authorized and nil, 50,000 and 50,000 shares issued and outstanding for 5% preferred stock and nil, 872,000 and 872,000 shares authorized, issued and outstanding for 7% 'A' preferred stock, as of June 30, 2026, December 31, 2025, and June 30, 2025, respectively | – | 1 | 1 | ||||||||
| Common stock, €0.32 par value, 1,250,000,000 shares authorized; 701,490,721, 706,946,142 and 711,792,599 issued and 665,895,636, 668,630,350 and 673,202,797 outstanding, as of June 30, 2026, December 31, 2025, and June 30, 2025, respectively | 284 | 286 | 288 | ||||||||
| Treasury stock, at cost (35,595,085, 38,315,792 and 38,589,802 shares as of June 30, 2026, December 31, 2025, and June 30, 2025, respectively) | (1,896) | (2,016) | (2,028) | ||||||||
| Additional paid-in capital | 285 | 397 | 323 | ||||||||
| Accumulated other comprehensive loss | (376) | (257) | (345) | ||||||||
| Retained earnings | 25,738 | 25,593 | 24,106 | ||||||||
| Total shareholders’ equity attributable to CRH shareholders | 24,035 | 24,004 | 22,345 | ||||||||
| Noncontrolling interests | 1,065 | 1,044 | 896 | ||||||||
| Total equity | 25,100 | 25,048 | 23,241 | ||||||||
| Total liabilities, redeemable noncontrolling interests and equity | 58,552 | 58,329 | 53,984 | ||||||||
CRH Q2 2026 Results 8
Exhibit 99.1
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in $ millions)
| Six months ended | ||||||||
| June 30 | ||||||||
| 2026 | 2025 | |||||||
| Cash Flows from Operating Activities: | ||||||||
| Net income | 1,331 | 1,234 | ||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation, depletion, and amortization | 1,124 | 1,005 | ||||||
| Loss on impairments | 48 | – | ||||||
| Share-based compensation | 73 | 66 | ||||||
| Gain on disposals from businesses and long-lived assets, net | (334) | (12) | ||||||
| Deferred tax expense | 31 | 5 | ||||||
| Loss from equity method investments | 2 | 9 | ||||||
| Pension and other postretirement benefits net periodic benefit cost | – | 12 | ||||||
| Non-cash operating lease costs | 164 | 134 | ||||||
| Other items, net | 6 | 2 | ||||||
| Changes in operating assets and liabilities, net of effects of acquisitions and divestitures: | ||||||||
| Accounts receivable, net | (1,824) | (1,397) | ||||||
| Inventories | (140) | (107) | ||||||
| Accounts payable | 248 | (58) | ||||||
| Operating lease liabilities | (167) | (153) | ||||||
| Other assets | (55) | (250) | ||||||
| Other liabilities | 23 | 249 | ||||||
| Pension and other postretirement benefits contributions | (21) | (20) | ||||||
| Dividends received from equity method investments | 4 | – | ||||||
| Net cash provided by operating activities | 513 | 719 | ||||||
| Cash Flows from Investing Activities: | ||||||||
| Purchases of property, plant and equipment, and intangibles | (1,240) | (1,300) | ||||||
| Acquisitions, net of cash acquired | (1,110) | (648) | ||||||
| Proceeds from divestitures | 1,676 | 37 | ||||||
| Proceeds from disposal of long-lived assets | 96 | 65 | ||||||
| Distributions received from equity method investments | – | 13 | ||||||
| Settlements of derivatives | (33) | (33) | ||||||
| Deferred divestiture consideration received | – | 38 | ||||||
| Other investing activities, net | 23 | 33 | ||||||
| Net cash used in investing activities | (588) | (1,795) | ||||||
CRH Q2 2026 Results 9
Exhibit 99.1
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in $ millions)
| Six months ended | ||||||||
| June 30 | ||||||||
| 2026 | 2025 | |||||||
| Cash Flows from Financing Activities: | ||||||||
| Proceeds from debt issuances | 1,552 | 4,542 | ||||||
| Payments on debt | (1,129) | (3,352) | ||||||
| Settlements of derivatives | (40) | 77 | ||||||
| Payments of finance lease obligations | (73) | (46) | ||||||
| Deferred and contingent acquisition consideration paid | (18) | (13) | ||||||
| Dividends paid | (521) | (500) | ||||||
| Distributions to noncontrolling and redeemable noncontrolling interests | (23) | (22) | ||||||
| Transactions involving noncontrolling interests | (24) | 2 | ||||||
| Repurchases of common stock | (607) | (644) | ||||||
| Amounts related to employee share plans | (66) | (56) | ||||||
| Net cash used in financing activities | (949) | (12) | ||||||
| Effect of exchange rate changes on cash and cash equivalents, including restricted cash | (40) | 205 | ||||||
| Decrease in cash and cash equivalents, including restricted cash | (1,064) | (883) | ||||||
| Cash and cash equivalents and restricted cash at the beginning of period | 4,147 | 3,759 | ||||||
| Cash and cash equivalents and restricted cash at the end of period | 3,083 | 2,876 | ||||||
| Supplemental cash flow information: | ||||||||
| Cash paid for interest (including finance leases) | 335 | 251 | ||||||
| Cash paid for income taxes | 404 | 304 | ||||||
| Reconciliation of cash and cash equivalents and restricted cash | ||||||||
| Cash and cash equivalents presented in the Condensed Consolidated Balance Sheets | 3,025 | 2,876 | ||||||
| Restricted cash presented in the Condensed Consolidated Balance Sheets | 58 | – | ||||||
| Total cash and cash equivalents and restricted cash presented in the Condensed Consolidated Statements of Cash Flows | 3,083 | 2,876 | ||||||
CRH Q2 2026 Results 10
Exhibit 99.1
Appendix 3 - Non-GAAP Reconciliation and Supplementary Information
CRH uses a number of non-GAAP financial measures to monitor financial performance. These measures are referred to throughout the discussion of our reported financial position and operating performance on a continuing operations basis unless otherwise defined and are measures which are regularly reviewed by CRH management. These financial measures may not be uniformly defined by all companies and accordingly may not be directly comparable with similarly titled measures and disclosures by other companies.
Certain information presented is derived from amounts calculated in accordance with U.S. GAAP but is not itself an expressly permitted GAAP measure. The non-GAAP financial measures as summarized below should not be viewed in isolation or as an alternative to the most directly comparable GAAP measure.
Adjusted EBITDA: Adjusted EBITDA is defined as earnings from continuing operations before interest, taxes, depreciation, depletion, amortization, loss on impairments, gain/loss on divestitures and investments, Income/loss from equity method investments, substantial acquisition-related costs and pension expense/income excluding current service cost component. It is quoted by management in conjunction with other GAAP and non-GAAP financial measures to aid investors in their analysis of the performance of the Company. Adjusted EBITDA by segment is monitored by management in order to allocate resources between segments and to assess performance.
Adjusted EBITDA margin is calculated by expressing Adjusted EBITDA as a percentage of Total revenues.
Reconciliation to its most directly comparable GAAP measure is presented below:
| Three months ended | Six months ended | |||||||||||||
| June 30 | June 30 | |||||||||||||
| in $ millions | 2026 | 2025 | 2026 | 2025 | ||||||||||
| Net income | 1,511 | 1,332 | 1,331 | 1,234 | ||||||||||
| (Income) loss from equity method investments | (9) | (1) | 2 | 9 | ||||||||||
| Income tax expense | 661 | 425 | 606 | 367 | ||||||||||
| (Gain) loss on divestitures and investments (i) | (266) | 16 | (260) | 42 | ||||||||||
| Pension income excluding current service cost component (i) | (13) | (5) | (18) | (9) | ||||||||||
| Other interest, net (i) | (3) | (2) | – | (4) | ||||||||||
| Interest income | (22) | (30) | (43) | (67) | ||||||||||
| Interest expense | 220 | 200 | 423 | 381 | ||||||||||
| Depreciation, depletion and amortization | 548 | 528 | 1,124 | 1,005 | ||||||||||
| Loss on impairments (ii) | – | – | 48 | – | ||||||||||
| Adjusted EBITDA | 2,627 | 2,463 | 3,213 | 2,958 | ||||||||||
| Total revenues | 10,777 | 10,206 | 18,147 | 16,962 | ||||||||||
| Net income margin | 14.0% | 13.1% | 7.3% | 7.3% | ||||||||||
| Adjusted EBITDA margin | 24.4% | 24.1% | 17.7% | 17.4% | ||||||||||
| (i) (Gain) loss on divestitures and investments, pension income excluding current service cost component and other interest, net have been included in Other nonoperating income (expense), net in the Condensed Consolidated Statements of Income. | ||||||||||||||
| (ii) For the six months ended June 30, 2026, Loss on impairments totalled $48 million, related to the International Solutions segment. | ||||||||||||||
Reconciliation to the most directly comparable GAAP measure for the mid-point of the 2026 Adjusted EBITDA guidance is presented below:
| in $ billions | 2026 Mid-Point | ||||
| Net income | 4.0 | ||||
| Income tax expense (i) | 1.4 | ||||
| Interest expense, net | 0.7 | ||||
| Depreciation, depletion and amortization | 2.3 | ||||
| Other (ii) | (0.1) | ||||
| Adjusted EBITDA | 8.3 | ||||
| (i) 2026 income tax expense mid-point guidance has been updated from the previous midpoint of $1.3 billion to $1.4 billion, reflecting the tax impact of recent divestitures. | |||||
| (ii) Other primarily relates to Other nonoperating (income) expense, net. | |||||
CRH Q2 2026 Results 11
Exhibit 99.1
Net Debt: Net Debt is used by management as it gives additional insight into the Company’s current debt position less available cash. Net Debt is provided to enable investors to see the economic effect of gross debt, related hedges and cash and cash equivalents in total. Net Debt comprises short and long-term debt, finance lease liabilities, cash and cash equivalents and current and noncurrent derivative financial instruments (net).
Reconciliation to its most directly comparable GAAP measure is presented below:
| June 30 | December 31 | June 30 | |||||||||
| in $ millions | 2026 | 2025 | 2025 | ||||||||
| Short and long-term debt | (17,926) | (17,653) | (15,813) | ||||||||
| Cash and cash equivalents | 3,025 | 4,096 | 2,876 | ||||||||
| Finance lease liabilities | (560) | (534) | (442) | ||||||||
| Derivative financial instruments (net) | 45 | (60) | (27) | ||||||||
| Net Debt | (15,416) | (14,151) | (13,406) | ||||||||
Organic Revenue and Organic Adjusted EBITDA: Because of the impact of acquisitions, divestitures, currency exchange translation and other non-recurring items on reported results each reporting period, CRH uses organic revenue and organic Adjusted EBITDA as additional performance indicators to assess performance of pre-existing (also referred to as underlying, like-for-like or ongoing) operations each reporting period.
Organic revenue and organic Adjusted EBITDA are arrived at by excluding the incremental revenue and Adjusted EBITDA contributions from current and prior year acquisitions and divestitures, the impact of exchange translation, and the impact of any one-off items. Changes in organic revenue and organic Adjusted EBITDA are presented as additional measures of revenue and Adjusted EBITDA to provide a greater understanding of the performance of the Company. Organic change % is calculated by expressing the organic movement as a percentage of the prior year (adjusted for currency exchange effects). A reconciliation of the changes in organic revenue and organic Adjusted EBITDA to the changes in Total revenues and Adjusted EBITDA by segment, is presented in Appendix 1.
CRH Q2 2026 Results 12
Exhibit 99.1
Appendix 4 - Disclaimer/Forward-Looking Statements
In reliance upon the “Safe Harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, CRH is providing the following cautionary statement.
This document contains statements that are, or may be deemed to be, forward-looking statements with respect to the financial condition, results of operations, business, viability and future performance of CRH and certain of the plans and objectives of CRH. These forward-looking statements may generally, but not always, be identified by the use of words such as “will”, “anticipates”, “should”, “could”, “would”, “targets”, “aims”, “may”, “continues”, “expects”, “is expected to”, “estimates”, “believes”, “intends” or similar expressions. These forward-looking statements include all matters that are not historical facts or matters of fact at the date of this document.
In particular, the following, among other statements, are all forward-looking in nature: plans and expectations regarding CRH's outlook for 2026, including market dynamics and demand among CRH's platforms; plans and expectations regarding public investment in infrastructure and continued reindustrialization activity; plans and expectations regarding pricing momentum, costs, demand, and trends in residential and non-residential markets and macroeconomic and other market trends and dynamics in key end-markets and other regions where CRH operates; expectations with respect to the impact of further potential changes to global trade policies; plans and expectations regarding acquisitions and divestitures; and statements regarding the consummation (including timing thereof) of the proposed merger (the 'Arcosa Acquisition') between CRH and Arcosa; the anticipated benefits of the Arcosa Acquisition, including expected synergies, accretion and financial impact; CRH’s expected financial performance following the completion of the Arcosa Acquisition; statements regarding the M&A pipeline and other value-accretive opportunities; statements regarding the reallocation of capital; plans and expectations regarding return of cash to shareholders, including the timing, consistency and amount of share buybacks and dividends; expectations regarding CRH's credit rating; and plans and expectations regarding CRH's 2026 full year performance, including net income, Adjusted EBITDA, diluted EPS, capital expenditures, assumed interest expense and assumed effective tax rate.
By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future and reflect the Company’s current expectations and assumptions as to such future events and circumstances that may not prove accurate. You are cautioned not to place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this document. The Company expressly disclaims any obligation or undertaking to publicly update or revise these forward-looking statements other than as required by applicable law.
A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, certain of which are beyond our control, and which include, but are not limited to: economic and financial conditions, including changes in interest rates, inflation, price volatility and/or labor and materials shortages; demand for infrastructure, residential and non-residential construction and our products in geographic markets in which we operate; increased competition and its impact on prices and market position; increases in energy, labor and/or other raw materials costs; adverse changes to laws and regulations, including in relation to climate change; the impact of unfavorable weather; investor and/or consumer sentiment regarding the importance of sustainable practices and products; availability of public sector funding for infrastructure programs; political uncertainty, including as a result of political and social conditions in the jurisdictions CRH operates in, or adverse political developments, including the ongoing geopolitical conflicts in Ukraine and the Middle East; failure to complete or successfully integrate acquisitions or make timely divestitures; cyber-attacks and exposure of associates, contractors, customers, suppliers and other individuals to health and safety risks, including due to product failures; the occurrence of any event, change or other circumstance that could give rise to the termination of the agreement relating to the Arcosa Acquisition; the failure to obtain the required approval of Arcosa’s stockholders; the failure to satisfy the other conditions to the completion of the Arcosa Acquisition, including the receipt of required regulatory approvals; risks that the Arcosa Acquisition disrupts CRH’s current plans and operations; the ability to recognize the anticipated benefits of the Arcosa Acquisition; the amount of costs, fees, expenses and charges related to the Arcosa Acquisition and the actual terms of the financing obtained in connection with the Arcosa Acquisition; diversion of management’s attention from ongoing business operations and opportunities; potential litigation relating to the Arcosa Acquisition; and the effect of the announcement or pendency of the Arcosa Acquisition on CRH’s and Arcosa’s business relationships, operating results and business generally. Additional factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those expressed by the forward-looking statements in this report including, but not limited to, the risks and uncertainties described herein and in “Risk Factors” in the 2025 Form 10-K and in our other filings with the SEC.
CRH Q2 2026 Results 13